Skip to main content
Get the Weekly ESG Brief

Amgen Inc.

AMGNNASDAQGSTrackedESG Rated: 2/2 ProvidersMarket Data VerifiedHealth CareBiotechnologyMSCI: AASustainalytics: 22.0 · Medium

Coverage
Rated universe Carries an MSCI or Sustainalytics observation.
ESG profile reviewed
Last editorial update to this profile.
Quote
Last verified closeObservation time is shown beside the price.
Methodology
How we rateProvider ratings are shown separately, never blended.

Market overview

USD 465.67

Down−USD 1.39 (−0.30%) Day change

Last verified close · As of · USD · Market data via Massive Stock Widgets

The market is closed. This is the last verified closing quote, not an intraday price.

Open
USD 467.53
Previous close
USD 467.06
Day high
USD 468.00
Day low
USD 462.22
Volume
2,122,345
Market cap
USD 251,886,256,128
Price chart · 1 Year
Amgen Inc. 1 Year price chartAmgen Inc., nasdaqgs:AMGN, 1 Year price chart in USD. Start USD 336.00, end USD 467.06, high USD 478.48, low USD 313.85, up.
Period1 YearFirst closeUSD 336.00Last closeUSD 467.06Maximum closeUSD 478.48Minimum closeUSD 313.85Period change+USD 131.06Period percentage change+39.01%Chart as ofNov 12, 2026, 2:30 PM GMT+0000
View Chart Data
Representative chart points — 24 of 251
Date and time Open High Low Close Volume
USD 337.90 USD 345.84 USD 335.12 USD 336.00 3,413,500
USD 321.82 USD 323.00 USD 313.18 USD 313.85 2,924,900
USD 328.77 USD 329.19 USD 325.01 USD 327.64 1,539,700
USD 328.70 USD 333.03 USD 326.90 USD 330.41 4,033,700
USD 341.24 USD 349.50 USD 338.59 USD 338.59 4,040,000
USD 377.91 USD 379.93 USD 374.13 USD 375.50 2,427,000
USD 364.20 USD 369.76 USD 361.71 USD 369.53 2,443,000
USD 351.80 USD 353.42 USD 348.61 USD 349.77 2,368,700
USD 345.61 USD 351.33 USD 342.35 USD 349.81 2,666,400
USD 345.52 USD 350.69 USD 345.50 USD 348.62 2,033,400
USD 329.48 USD 332.33 USD 328.00 USD 331.70 2,443,200
USD 340.26 USD 343.80 USD 338.40 USD 339.30 1,566,200
USD 348.24 USD 349.64 USD 342.62 USD 344.57 3,388,200
USD 350.06 USD 359.10 USD 350.06 USD 352.82 2,340,900
USD 363.04 USD 363.29 USD 355.73 USD 360.45 2,064,700
USD 383.25 USD 398.00 USD 382.21 USD 393.10 3,413,000
USD 413.31 USD 418.19 USD 409.00 USD 416.18 2,065,500
USD 433.08 USD 442.13 USD 431.01 USD 436.99 1,761,500
USD 381.94 USD 384.61 USD 376.76 USD 381.50 2,714,400
USD 411.52 USD 419.02 USD 410.96 USD 418.13 2,917,900
USD 420.34 USD 420.35 USD 411.04 USD 412.84 2,319,600
USD 441.03 USD 454.66 USD 439.57 USD 451.83 2,910,500
USD 479.61 USD 482.48 USD 464.13 USD 478.48 4,618,500
USD 471.86 USD 474.00 USD 466.92 USD 467.06 2,827,600

Company Profile & Business Model Overview

Amgen Inc. is a leading company in its sector with strong market presence and growth prospects.

Sustainability Strengths & Catalysts (Pros)

  • Has a strong product pipeline with potential blockbuster drugs in development
  • Is a leader in the biotechnology space and has a large market share
  • Has a good ESG rating

Material Risks & Governance Concerns (Cons)

  • Its recent performance has been lacklustre
  • Faces stiff competition from other companies in the space

Related ESG Peer Equities

Companies in Health Care evaluated across carbon intensity, social metrics, and board governance.

Explore Health Care Peers →

ESG & Sustainability Rating Breakdown

MSCI and Sustainalytics ratings shown side by side, never blended into a single score.

Third-party ratings

MSCI ESG Rating

AA

MSCI ESG industry rating benchmark.Rating date not recorded

Sustainalytics Risk Score

22.0

MediumScore date not recorded

Data integrity and methodology

MSCI and Sustainalytics ratings are shown separately with their own observation dates; they are not blended into one score, and providers can disagree. Market quotes are delayed or last-close values, and every snapshot states its source and observation time. Read the full rating methodology.

FAQ

Frequently Asked Questions

Direct answers on sustainability scores, risk methodologies, and peer rankings.

What is Amgen Inc. (AMGN)'s ESG rating and sustainability score?

Amgen Inc. (AMGN) currently holds an MSCI ESG rating of AA and a Sustainalytics ESG Risk Score of 22.0 (Medium risk). Ratings evaluate environmental emissions, labor standards, board independence, and regulatory compliance.

Is Amgen Inc. considered an ESG leader or laggard in Health Care?

Amgen Inc. is classified as an ESG Leader by MSCI with a AA rating, ranking in the top tier of companies in Health Care for sustainability governance and decarbonization practices.

What are the main ESG risks and controversies for Amgen Inc.?

Key material risks for Amgen Inc. include: Its recent performance has been lacklustre; Faces stiff competition from other companies in the space. Investors should evaluate whether corporate mitigation plans adequately address these vulnerabilities.

How does The Impact Investor evaluate ESG stock profiles?

The Impact Investor presents third-party ratings from MSCI and Sustainalytics alongside delayed market data and financial fundamentals. We do not blend ratings into proprietary black-box scores, and ratings are never modified by advertising or affiliate relationships.